iOmx Therapeutics
iomx.com
Actively hiring
Cancer Care Centers
Drug Discovery
As featured in
View 1 job
Claim pageClaim
Follow
Overview
Connections
News
Salaries
Products
People
Growth
Offices
Jobs
Financials
Overview
See how iOmx transforms deep tumor biology into breakthrough immunotherapies. Explore our pipeline, technology and careers — join us in advancing cancer care.
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
M VenturesVia a fund
Sofinnova PartnersVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
iOmx Therapeutics to Present Target Discovery Platform Myeloid iOTarg and New Data on SIK Checkpoint Inhibitor OMX-0407 at AACR 2023
Discovery of novel immune checkpoints in the tumor microenvironment with iOTarg screening platformPredictive biomarker signature for lead product candidate OMX-0407 MUNICH, Germany, March 15, 2023 (GLOBE NEWSWIRE) -- iOmx Therapeutics AG, a biopharmaceuti
Read more
Report
Growth
Hiring Momentum
23/100
Hiring freeze
Open positions
1
0 opened / 0 closed in 30 days
Median time-to-fill
70 days
faster than 18% of the market
ATS activity
Every ~5 hours
Today
Hiring Dynamics
0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Operations
50% ▼
Science & Research
50% ▼
Jobs
Apply